rs61758100

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015294.6(TRIM37):​c.398C>T​(p.Ala133Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00808 in 1,613,754 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A133G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0064 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0083 ( 69 hom. )

Consequence

TRIM37
NM_015294.6 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 7.67

Publications

7 publications found
Variant links:
Genes affected
TRIM37 (HGNC:7523): (tripartite motif containing 37) This gene encodes a member of the tripartite motif (TRIM) family, whose members are involved in diverse cellular functions such as developmental patterning and oncogenesis. The TRIM motif includes zinc-binding domains, a RING finger region, a B-box motif and a coiled-coil domain. The RING finger and B-box domains chelate zinc and might be involved in protein-protein and/or protein-nucleic acid interactions. Mutations in this gene are associated with mulibrey (muscle-liver-brain-eye) nanism, an autosomal recessive disorder that involves several tissues of mesodermal origin. TRIM37 localizes in peroxisomal membranes, and has been implicated in human peroxisomal biogenesis disorders. [provided by RefSeq, Jul 2020]
TRIM37 Gene-Disease associations (from GenCC):
  • mulibrey nanism
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008718789).
BP6
Variant 17-59081191-G-A is Benign according to our data. Variant chr17-59081191-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 198216.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0064 (974/152202) while in subpopulation NFE AF = 0.011 (750/68020). AF 95% confidence interval is 0.0104. There are 4 homozygotes in GnomAd4. There are 497 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIM37NM_015294.6 linkc.398C>T p.Ala133Val missense_variant Exon 6 of 24 ENST00000262294.12 NP_056109.1 O94972-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIM37ENST00000262294.12 linkc.398C>T p.Ala133Val missense_variant Exon 6 of 24 1 NM_015294.6 ENSP00000262294.7 O94972-1

Frequencies

GnomAD3 genomes
AF:
0.00640
AC:
974
AN:
152084
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0110
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00630
AC:
1583
AN:
251448
AF XY:
0.00630
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0129
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.00717
GnomAD4 exome
AF:
0.00825
AC:
12061
AN:
1461552
Hom.:
69
Cov.:
30
AF XY:
0.00806
AC XY:
5860
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.000896
AC:
30
AN:
33470
American (AMR)
AF:
0.00161
AC:
72
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
37
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39652
South Asian (SAS)
AF:
0.000939
AC:
81
AN:
86252
European-Finnish (FIN)
AF:
0.0130
AC:
694
AN:
53362
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.00972
AC:
10808
AN:
1111826
Other (OTH)
AF:
0.00553
AC:
334
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
592
1184
1777
2369
2961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00640
AC:
974
AN:
152202
Hom.:
4
Cov.:
32
AF XY:
0.00668
AC XY:
497
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41528
American (AMR)
AF:
0.00203
AC:
31
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.0104
AC:
110
AN:
10572
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0110
AC:
750
AN:
68020
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
53
105
158
210
263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00815
Hom.:
13
Bravo
AF:
0.00519
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.00919
AC:
79
ExAC
AF:
0.00692
AC:
840
Asia WGS
AF:
0.000578
AC:
2
AN:
3476
EpiCase
AF:
0.00834
EpiControl
AF:
0.00717

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Nov 15, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRIM37: BS1, BS2 -

not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 16, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mulibrey nanism syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T;T;.
Eigen
Benign
0.064
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.95
.;D;D
MetaRNN
Benign
0.0087
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.0
N;N;.
PhyloP100
7.7
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.057
Sift
Benign
0.090
T;T;T
Sift4G
Benign
0.088
T;T;T
Polyphen
0.057
B;B;.
Vest4
0.30
MVP
0.41
MPC
0.72
ClinPred
0.016
T
GERP RS
5.6
PromoterAI
-0.051
Neutral
Varity_R
0.17
gMVP
0.57
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61758100; hg19: chr17-57158552; COSMIC: COSV51889288; COSMIC: COSV51889288; API